Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

New Brain Protein Clumping Study Could Bring Gadolinium Retention Help

Researchers studying ALS and Dementia noticed damage proteins will clump inside the brain. Then, these proteins will affect cells within the nephropathy. Experts are wondering if gadolinium retention happens in a similar fashion. Also, if the treatment could extend to this neurotoxicity as well.

About Gadolinium Retention

Gadolinium ToxicityGadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a group of elements in the periodic table called Lanthanides, the chemical is a rare earth element. Microwave applications, color TV tubes, synthetic gemstones, compact discs, and computer memory typically use the chemical. Also, the medical community uses this chemical element as an injectable contrast agent when patients undergo MRI or MRA scans.
The medical community believes that after they inject the body with this dye, it expels it naturally within a few hours. However, this is not always the case. The chemical agent can also stay in the body for months or years following a single imaging session. Therefore, it causes the body to develop a whole range of debilitating symptoms like brain fog, ligament tightening, balance problems, hair loss, cognitive symptoms and more.

Protein Clumping Study

In a study published last month by Neuron, researchers studied TDP-43 for more than a decade. TDP-43 is a DNA-binding protein in the brain. When exposed to toxicity such as ALS or Dementia, this protein will ball up. Many had no idea why.  These group of researchers discovered that proteins ball or clump when there aren’t any RNA (ribonucleic acid) to bind to. Proteins need to attach to RNA to function normally. When the researchers introduced a synthetic RNA replacement, the protein clumping stopped.
This treatment could potentially help those with gadolinium retention. Gadolinium also builds up in proteins in the brain. However, there aren’t any treatments that fully expel the chemical agent from the body.

Current Treatments for Gadolinium Retention

Treatment for GDD can be costly and expansive. It involves combination of rechelation and immune system modulation. Chelation is a medical process involving administering chelating agents to bond with metal ions to form a more chemically stable compound to safely excrete GBCA from the body. The FDA has not approved this process. The chemicals used in the process are only FDA approved for the removal of lead. Many don’t realize that the process removes important nutrients like calcium and zinc, too.
Plus, research shows that this process doesn’t remove all the gadolinium anyway. Also, symptoms can worsen.

IV Chelation

IV chelation is the strongest approach. The doctor will conduct a urine test to determine the body burden of various toxic substances.  He or she will then determine the appropriate chelating agent(s) and recommend a course of treatment.  Treatments are usually done between one and three times a week for a total of more than 20 sessions. Many people have had 50 treatments. Each treatment costs from $100 to $250 per session, and insurance doesn’t usually cover them.

Oral Chelation

Oral chelation is usually a pill taken under the advisement of a doctor. Usually, supplements are needed to counteract the removal of good minerals by the chelating agent as it removes the toxic heavy metals. There are also sublingual powders used under the tongue instead of going through the digestive process.
Now, if further research proves correct due to the similarities between different neurodegenerative diseases, synthetic RNA introduction could help de-clump proteins associated with toxicity like gadolinium retention.

Free Case Evaluation

Financial HelpA gadolinium lawsuit may be an option for patients suffering from gadolinium retention and related complications. Gadolinium, used in dyes to increase the clarity of MRI and MRA scans, can create chemical element retention in the body, Therefore, this increases the risk of gadolinium deposition disease and nephrogenic systemic fibrosis. These conditions are accompanied by symptoms that include severe physical pain and cognitive difficulties. Affected patients and their loved ones may be able to file a lawsuit and recover damages.
For more information, contact The Michael Brady Lynch Firm. We offer free, confidential, no-obligation consultations. We have also over 20 years of experience helping consumers injured by unsafe products manufactured by large companies.

×
What Our Clients Are Saying